AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
AMGEN INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$424.94−7.55 (-1.75%)
Close on Oct 19, 2026
- Market cap
- $231.17B
- P/E (TTM)
- 26.4
- Dividend yield
- 2.27%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$9.66
+5.8% on the prior year
Consecutive increases
9 years
Every year since FY2016
Dividend yield
2.27%
Latest annual dividend ÷ share price
Payout ratio, FY2025
66.5%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $9.66 | +5.8% | $5.12B | 66.5% |
| FY2024 | $9.13 | +5.7% | $4.83B | 118.1% |
| FY2023 | $8.64 | +8.7% | $4.56B | 67.8% |
| FY2022 | $7.95 | +10.1% | $4.20B | 64.0% |
| FY2021 | $7.22 | +10.1% | $4.01B | 68.1% |
| FY2020 | $6.56 | +10.3% | $3.76B | 51.7% |
| FY2019 | $5.95 | +10.0% | $3.51B | 44.7% |
| FY2018 | $5.41 | +13.4% | $3.51B | 41.8% |
| FY2017 | $4.77 | +14.9% | $3.37B | 170.0% |
| FY2016 | $4.15 | – | $3.00B | 38.8% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.